| Literature DB >> 17409221 |
C B Willberg1, S K Pillai, E R Sharp, M G Rosenberg, J D Agudelo, J D Barbour, D F Nixon.
Abstract
Understanding human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses is important for the development of vaccines and therapies. We describe a novel method for the rational selection of peptides that target stable regions of the HIV-1 genome, rich in epitopes specifically recognized by the study population. This method will be of particular use under resource/sample-limited conditions.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17409221 PMCID: PMC1951093 DOI: 10.1128/CVI.00048-07
Source DB: PubMed Journal: Clin Vaccine Immunol ISSN: 1556-679X